Skip to main content

Cincinnati Financial (NASDAQ:CINF) PT Raised to $110.00

Tuesday, May 4, 2021 | MarketBeat

Cincinnati Financial (NASDAQ:CINF) had its price target upped by stock analysts at Deutsche Bank Aktiengesellschaft from $88.00 to $110.00 in a research report issued on Tuesday, The Fly reports. The firm presently has a "hold" rating on the insurance provider's stock. Deutsche Bank Aktiengesellschaft's price objective would indicate a potential downside of 4.26% from the stock's current price.

A number of other equities research analysts have also issued reports on CINF. Zacks Investment Research upgraded shares of Cincinnati Financial from a "hold" rating to a "buy" rating and set a $93.00 price target on the stock in a report on Thursday, February 11th. Royal Bank of Canada boosted their price objective on shares of Cincinnati Financial from $105.00 to $110.00 and gave the company an "outperform" rating in a research report on Tuesday, April 20th. Finally, MKM Partners boosted their price objective on shares of Cincinnati Financial from $110.00 to $130.00 and gave the company a "buy" rating in a research report on Thursday, March 18th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and three have issued a buy rating to the company's stock. The company currently has a consensus rating of "Hold" and an average price target of $99.40.

CINF stock opened at $114.90 on Tuesday. Cincinnati Financial has a 52-week low of $46.07 and a 52-week high of $115.43. The company's 50 day simple moving average is $106.81 and its 200-day simple moving average is $91.23. The company has a debt-to-equity ratio of 0.10, a current ratio of 0.28 and a quick ratio of 0.28. The firm has a market capitalization of $18.51 billion, a P/E ratio of 23.69 and a beta of 0.59.

Cincinnati Financial (NASDAQ:CINF) last released its quarterly earnings results on Wednesday, April 28th. The insurance provider reported $1.37 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $1.05 by $0.32. The firm had revenue of $2.23 billion for the quarter, compared to analyst estimates of $1.68 billion. During the same quarter in the prior year, the firm earned $0.84 EPS. The firm's revenue was down 2349.5% compared to the same quarter last year. Sell-side analysts predict that Cincinnati Financial will post 2.81 EPS for the current fiscal year.

Institutional investors and hedge funds have recently made changes to their positions in the stock. Ascension Asset Management LLC bought a new stake in Cincinnati Financial in the first quarter worth approximately $1,714,000. Valmark Advisers Inc. bought a new stake in Cincinnati Financial in the first quarter worth approximately $534,000. Daiwa Securities Group Inc. grew its position in Cincinnati Financial by 2.6% in the first quarter. Daiwa Securities Group Inc. now owns 8,089 shares of the insurance provider's stock worth $834,000 after acquiring an additional 204 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its position in Cincinnati Financial by 0.6% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 41,623 shares of the insurance provider's stock worth $4,291,000 after acquiring an additional 251 shares in the last quarter. Finally, Advanced Asset Management Advisors Inc bought a new stake in Cincinnati Financial in the first quarter worth approximately $208,000. 65.26% of the stock is currently owned by hedge funds and other institutional investors.

About Cincinnati Financial

Cincinnati Financial Corporation, together with its subsidiary, provides property casualty insurance products in the United States. The company operates through five segments: Commercial Lines Insurance, Personal Lines Insurance, Excess and Surplus Lines Insurance, Life Insurance, and Investments. The Commercial Lines Insurance segment offers coverage for commercial casualty, commercial property, commercial auto, and workers' compensation.

See Also: Dollar Cost Averaging

The Fly

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]

Featured Article: Momentum Indicator: Relative Strength Index


7 Healthcare Stocks Delivering Innovation in 2021

We all knew that traditional healthcare services were disrupted in 2020. The patient-doctor relationship went virtual. In the early months of the pandemic, many people in need of elective surgeries simply did not have that option available to them. And even local pharmacies took on a new e-commerce role as curbside pickup or home delivery of prescription medication became the norm.

Not surprisingly healthcare stocks were battered last year. Overall, the sector was down 11%, far below the S&P 500 Index that climbed over 15%.

However, the market is always forward-looking with a particular eye towards innovation. The healthcare sector has many companies that are developing innovative approaches in areas such as gene editing. And other companies are in late-stage trials for drugs that can deliver breakthrough results for conditions that continue to plague our world.

That’s the focus of this presentation. We’ve identified 7 healthcare stocks that are delivering innovative ideas that will help deliver better patient outcomes. And in some cases will revolutionize medicine altogether. These are also the stocks that analysts have their eye on.

View the "7 Healthcare Stocks Delivering Innovation in 2021".


MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.